Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Mvp Fhir Licensing topic
No spam. Unsubscribe anytime.
CMS urges move to MVPs and FHIR; says QCDR owners are not required to license proprietary measures
Summary
CMS presenters reiterated the goal to prioritize MVPs and FHIR‑specified digital measures and told attendees QCDR measure owners are not required to grant license rights; CMS asked registries to document failed collaboration attempts and encouraged preview calls.
Dr. Michelle Schreiber and Marlene Jones‑Pool of CMS said during the webinar that CMS is prioritizing MIPS Value Pathways (MVPs) and digital quality measures specified for FHIR to reduce clinician reporting burden and better align measures across programs.
"At some point in the future, we will be looking for measures to be digital and FHIR specified," Dr. Schreiber said, noting CMS is building FHIR servers and has specified electronic clinical quality measures for FHIR. Marlene Jones‑Pool added that QCDRs and qualified registries must support MVPs applicable to their clinicians within one year after an MVP is finalized, with an example that measures finalized in the 2026 Physician Fee Schedule Final Rule must be supported by Jan. 1, 2027.
In Q&A, an attendee asked whether measure owners are required to license proprietary measures to other QCDRs when MVPs depend on such measures. Olga Kogan of PIQMMS responded: "You are not required to support other QCDR measures. We do make a deliberate effort not to create MVPs that rely solely on QCDR measures," and advised QCDRs to document any attempts to collaborate and share that documentation with CMS if they encounter licensing roadblocks.
On a related question about whether an expanded QCDR measure that builds on an existing MIPS Quality ID (QID 507) would cause CMS to remove the original QID, Kogan said CMS evaluates such situations case‑by‑case and generally gives preference to existing MIPS quality measures but will only make final decisions after reviewing submitted specifications. She encouraged developers to schedule preview calls and to include relevant information by the April 3 change‑request deadline when the change may affect MVPs.
The panel reiterated that CMS encourages QCDRs to resolve duplications among themselves when possible and to borrow measures with written permission; where duplication persists, CMS may select the most robust measure or prefer the MIPS quality measure for wider availability.
Next steps: QCDRs with concerns about licensing or cross‑QCDR dependencies should document outreach and request preview calls early.
